TEMPE, Ariz., Feb. 12, 2015 /PRNewswire-iReach/ — PROTEOR USA a developer of next-generation prosthetic devices announced a new exclusive distribution relationship with German-based Protheseus GmbH, for its flagship products the RUSH® HiPro and the RUSH®LoPro prosthetic feet.
The agreement offers exclusive distribution of PROTEOR USA’ products within the borders of Germany, Austria and Poland to O&P customers.
“We couldn’t be happier with this new agreement”, said J. Blount Swain, President of PROTEOR USA. Swain continued, “Central Europe is key to our International expansion plans, especially the German market.”
“Wolfgang and Johanna Neuhof’s reputation as a leader in the O&P industry makes this agreement a perfect fit for PROTEOR USA.” Swain added. “These are exactly the types of relationships we are seeking”
Additionally, PROTEOR USA has also secured distribution in Australia, Canada, and Israel and is actively pursuing distributorships in several other countries.
About PROTEOR USA Company
PROTEOR USA is a full service manufacturer of next-generation prosthetic devices (https://rushfoot.com) which offers customers a range of quality products and services to suit their needs. PROTEOR USA understanding and experience in the industry is unparalleled. For more information visit: https://rushfoot.com
About Protheseus GmbH
With more than 20 years of experience in the O+P field Wolfgang and Johanna Neuhof founded the Protheseus GmbH, Germany, in 2012.
Together with their highly motivated team of professionals they provide best service to their customers, they offer same day shipment and educational programs for latest technologies in their seminar-center. Protheseus is located in Schwabach, Germany, near the city of Nürnberg and is serving customers in Germany and Austria as well as some other European countries. The personal and trustful relationship with customer and supplier over all the years is their most valued asset. For more information visit: www.protheseus.de
Media Contact: Holly Sanger, PROTEOR USA, 480-361-1303, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com